We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
Consensus vs. actual, and revenue trend
| 분기 | 발표일 | 시각 | EPS 예상 | EPS 실제 | 서프라이즈 | 매출 예상 | 매출 실제 | 상태 |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 04. | 장 마감 후 (AMC) | $1.41 | — | — | $398.4M | — | 예정 |
| FY2026 Q1 | 2025. 03. 29. | 시각 미정 | — | $-3.12 | — | — | $372M | 보고됨 |
| FY2025 Q3 | 2024. 09. 28. | 시각 미정 | — | $0.83 | — | — | $1.03B |
Consensus PT $180 · 4 analysts
| 날짜 | 리서치펌 | 애널리스트 | 액션 | 의견 변화 | 목표가 | 리포트 |
|---|---|---|---|---|---|---|
| 2026. 03. 28. | Raymond James | — | 투자의견 하향 | Outperform → Market Perform | — | Raymond James: Outperform → Market Perform |
| 2026. 02. 18. | Wells Fargo | — | 투자의견 하향 | Overweight → Equal-Weight | — | Wells Fargo: Overweight → Equal-Weight |
동일 리서치펌의 과거 의견 변화, 동일 섹터 내 다른 종목 액션과 비교 가능
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
| FY2025 Q2 | 2024. 06. 29. | 시각 미정 | — | $0.64 | — | — | $683.5M | 보고됨 |
Automated summary from public sources · not investment advice
공시·실적·기관 변화를 한국어 한 단락으로 요약. 원문 출처와 함께 제공됩니다.
Ranked by position value
| # | 기관 | 운용 형태 | 보유 주식 | 평가액 | 비중 | 변화율 | 포지션 |
|---|---|---|---|---|---|---|---|
| 1 | SOROS FUND MANAGEMENT LLC | SOROS FUND MANAGEMENT LLC | 100,838 | $17.94B | 0.32% | — | 신규 편입 |
신규 편입·전량 매도·비중 변화까지 모두 확인할 수 있습니다.
Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
Stored first · Google News · Yahoo Finance (English)
Danaher Masimo Deal Shifts Growth Outlook And Investor Focus - Yahoo Finance
Danaher Masimo Deal Shifts Growth Outlook And Investor Focus Yahoo Finance
Masimo Corporation (MASI) Rose Following the Acquisition Announcement - Yahoo Finance
Masimo Corporation (MASI) Rose Following the Acquisition Announcement Yahoo Finance
Masimo (MASI) Net Margin Recovery Reinforces Bullish Earnings Narratives In Q1 2026 - simplywall.st
Masimo (MASI) Net Margin Recovery Reinforces Bullish Earnings Narratives In Q1 2026 simplywall.st
Masimo shareholders approve its $9.9B acquisition by Danaher - Modern Healthcare
Masimo shareholders approve its $9.9B acquisition by Danaher Modern Healthcare
Masimo shareholders give green light to $10B acquisition by Danaher - MassDevice
Masimo shareholders give green light to $10B acquisition by Danaher MassDevice
Is Masimo Corporation (MASI) A Good Stock To Buy Now? - Yahoo Finance
Is Masimo Corporation (MASI) A Good Stock To Buy Now? Yahoo Finance